GENA-25 Hemophilia A

Bleeding and Clotting Disorders

Protocol:GENA-25

Condition or Disease: Hemophilia A

Study Type: Observational

Status: Open for enrollment

Study Title: PRactical utilization of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment (with Nuwiq, Octanate or Wilate) ‰ÛÒ A Real- World Efficacy and Safety Observational Study

Principal I investigator: Joseph Lasky III, MD

More Info: //clinicaltrials.gov/ct2/show/NCT03695978

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News